Report cover image

Antigen Discovery Inc - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Apr 08, 2024
Length 24 Pages
SKU # GBDT18719595

Description

Summary


Antigen Discovery Inc (ADI) is a biomarker discovery company that offers research services and products using high throughput protein microarray technology. The company provides products such as protein microarrays, elisa, human proteome microarray, soluble proteome, and others. It provides services such as expert statistical analysis, proteome screening; vaccine development and efficacy monitoring, diagnostic content discovery, biomarker discovery and drug validation, among others. ADI’s proteomics approach enables the identification of proteins useful for the development of a wide range of therapeutics, vaccines, diagnostics, and others. The company partners with pharmaceutical and biotechnology companies, universities, medical centers, and consortiums working in the areas of infectious disease and vaccine development. ADI is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Antigen Discovery Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company

Table of Contents

24 Pages
Antigen Discovery Inc Company Overview
Antigen Discovery Inc Company Snapshot
Antigen Discovery Inc Pipeline Products and Ongoing Clinical Trials Overview
Antigen Discovery Inc – Pipeline Analysis Overview
Antigen Discovery Inc - Key Facts
Antigen Discovery Inc - Major Products and Services
Antigen Discovery Inc Pipeline Products by Development Stage
Antigen Discovery Inc Pipeline Products Overview
ELISA Based Rapid Test - COVID-19
ELISA Based Rapid Test - COVID-19 Product Overview
Microfluidic Point of Care Device
Microfluidic Point of Care Device Product Overview
Pan-Proteome Microarray Test - Syphilis
Pan-Proteome Microarray Test - Syphilis Product Overview
POC Test - COVID-19/Influenza
POC Test - COVID-19/Influenza Product Overview
Serodiagnostic Assay - YFV
Serodiagnostic Assay - YFV Product Overview
Vaccine Mediated Protection Diagnostic Test
Vaccine Mediated Protection Diagnostic Test Product Overview
Antigen Discovery Inc - Key Competitors
Antigen Discovery Inc - Key Employees
Antigen Discovery Inc - Locations And Subsidiaries
Head Office
Recent Developments
Antigen Discovery Inc, Recent Developments
Feb 15, 2017: Discovery of biomarkers associated with 100% protection by PfSPZ-CVac against malaria published in Nature
Aug 15, 2012: Antigen Discovery Receives Phase I SBIR Grant To Develop Fully Integrated Microfluidic Point Of Care Diagnostic Device
Aug 13, 2012: Antigen Discovery receives Phase II SBIR grant to identify biomarkers associated with protection against malaria
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Antigen Discovery Inc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Antigen Discovery Inc Pipeline Products by Equipment Type
Table 3: Antigen Discovery Inc Pipeline Products by Indication
Table 4: Antigen Discovery Inc, Key Facts
Table 5: Antigen Discovery Inc, Major Products and Services
Table 6: Antigen Discovery Inc Number of Pipeline Products by Development Stage
Table 7: Antigen Discovery Inc Pipeline Products Summary by Development Stage
Table 8: ELISA Based Rapid Test - COVID-19 - Product Status
Table 9: ELISA Based Rapid Test - COVID-19 - Product Description
Table 10: Microfluidic Point of Care Device - Product Status
Table 11: Microfluidic Point of Care Device - Product Description
Table 12: Pan-Proteome Microarray Test - Syphilis - Product Status
Table 13: Pan-Proteome Microarray Test - Syphilis - Product Description
Table 14: POC Test - COVID-19/Influenza - Product Status
Table 15: POC Test - COVID-19/Influenza - Product Description
Table 16: Serodiagnostic Assay - YFV - Product Status
Table 17: Serodiagnostic Assay - YFV - Product Description
Table 18: Vaccine Mediated Protection Diagnostic Test - Product Status
Table 19: Vaccine Mediated Protection Diagnostic Test - Product Description
Table 20: Antigen Discovery Inc, Key Employees
Table 21: Glossary
List of Figures
Figure 1: Antigen Discovery Inc Pipeline Products by Equipment Type
Figure 2: Antigen Discovery Inc Pipeline Products by Development Stage

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us